The North Shore-LIJ Health System announced today it is seeking participants for a new clinical trial that will test a new chemotherapy option for patients with liver tumors.

New Hyde Park, NY (Vocus/PRWEB ) April 17, 2007 -- The North Shore-LIJ Health System announced today it is seeking participants for a new clinical trial that will test a new chemotherapy option for patients with liver tumors.

The clinical trial is being led by T.S. Ravikumar, MD, chairman of surgery at North Shore University Hospital and LIJ Medical Center. The North Shore-LIJ Health System is the nation's only healthcare provider offering this care.

This trial is investigating targeting tumors with a combination of Radiofrequency Thermal Ablation (RFA) and an experimental drug, ThermoDoxTM. Patients with primary and metastatic liver tumors are eligible for this trial. ThermoDoxTM Is a proprietary Product of Celsion Corporation (CLN), which is also the sponsor of this clinical program.

RFA is becoming standard therapy for many inoperable patients with liver tumors. A special needle electrode is placed in the tumor under the guidance of an imaging method, such as ultrasound or computed tomography (CT) scanning. A radiofrequency current then is passed through the electrode to heat the tumor tissue near the needle tip and may, in some cases, ablate--or eliminate--it. The heat from radiofrequency energy also closes up small blood vessels, thereby minimizing the risk of bleeding.

This trial combines RFA with the local delivery of chemotherapy in one procedure. The drug (ThermoDoxTM¬) is given intravenously during RFA, and released locally near the RFA zone when the capsule leaks from heat and chemotherapy is deposited locally in and around the tumor. The hope is that this will minimize side effects, and make the chemotherapy more targeted.

Patients 18 years of age and older who have primary or metastatic liver cancer may be eligible for this study. Candidates are screened with a medical history, physical examination, blood tests, electrocardiogram, and imaging studies such as CT, or magnetic resonance imaging (MRI). Those tests are repeated at various intervals during the study to monitor treatment effects.

According to the National Cancer Institute, an estimated 16,780 deaths occur annually in the United States from liver cancer, and an additional 19,000 new cases are being diagnosed every year. In addition, a large number of patients develop tumors in the liver, spread from other organs such as the colon or rectum

For more information on the study, please contact Karen Fehn, RN, research coordinator, at 516-562-2933 or kfehn(at)nshs.edu. More information can be found at www.northshorelij.com or www.clinicaltrials.gov.

###

Simillar Articles

Liver Problems and Liver Disease: Doctor De-Mystifies the Mysterious Liver

Most people have heard of cirrhosis of the liver, which usually results from alcohol abuse. But few people are aware of the other common problems that can affect the liver. A new website featuring...

Liver Damage and Lindsay Lohan: New Liver Damage Awareness for Young Adults

Reports of possible liver damage from alcohol abuse by actress Lindsay Lohan have helped debunk the myth that liver damage and cirrhosis of the liver can't happen to someone in their 20s.

A "Growing" Liver Problem: Thin Outside, Fat Inside

"Internal flab" associated with fatty liver disease is becoming a bigger liver problem than cirrhosis in the United States and Canada, and most people have no idea that they're at risk.

Liver Metastasis Remains a Major Threat to Cancer Survivors

Recent cases on headline news about liver metastasis such as Tony Snow's recent diagnosis derived from his primary colon cancer, underscores the fact that liver metastasis is a major threat to...

Baptist Interventional Radiologist Uses Advanced Techniques to Precisely Attack Cancer Tumors,...

Baptist board certified physicians take multidisciplinary team approach to treating tumors.

Home